BANZEL
Live / Registered — Registered and renewed (as of 06 Dec 2018)
What this means for you
Registered since 28 Apr 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Apr 2019).
Record
- Serial number
- 77334627
- Registration number
- 3613307
- Mark type
- Stylized text
- Filed
- 20 Nov 2007
- Published for opposition
- 25 Mar 2008
- Registered
- 28 Apr 2009
- Next maintenance due
- 28 Apr 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of epilepsy, central nervous system diseases and disorders, and neurological diseases and disorders
Owner
- NOVARTIS AG, BASEL, CH
- Eisai R&D Management Co., Ltd., Tokyo, JP
- Eisai R&D Management Co., Ltd., Tokyo, JP
- Eisai R&D Management Co., Ltd., Tokyo, JP
Prosecution history
- 06 Dec 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 06 Dec 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 06 Dec 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Dec 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Nov 2018 — TEAS SECTION 8 & 9 RECEIVED
- 28 Apr 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Apr 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Apr 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Apr 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Mar 2015 — TEAS SECTION 8 & 15 RECEIVED
- 30 Mar 2011 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Apr 2009 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 2009 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 19 Mar 2009 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Mar 2009 — STATEMENT OF USE PROCESSING COMPLETE